Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 07, 2026 16:01 ET | Source: Annexon Biosciences

Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones

Topline Pivotal Phase 3 Data for Vonaprument for the Treatment of Geographic Atrophy (GA) Expected Q4 2026, with Potential to Redefine Vision Preservation in GA Tanruprubart EU Marketing...
May 07, 2026 16:01 ET | Source: Denali Therapeutics Inc.

Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights

FDA approved AVLAYAH™ (tividenofusp alfa-eknm) for treatment of Hunter syndrome (MPS II) and as first medicine to leverage transferrin receptor to cross blood-brain barrierAVLAYAH launched in U.S....
May 07, 2026 16:01 ET | Source: Corvus Pharmaceuticals, Inc.

Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results

Soquelitinib clinical development for atopic dermatitis advancing with Phase 1 cohort 4 positive data and initiation of Phase 2 trial during the quarter New immunologic and biomarker data supporting...
May 07, 2026 16:01 ET | Source: Turtle Beach, Inc.

Turtle Beach Corporation Announces First Quarter 2026 Results

–Generated $29.4 Million in Cash Flow from Operations––Reaffirmed Full Year 2026 Net Revenue and Adjusted EBITDA Guidance– SAN DIEGO, May 07, 2026 (GLOBE NEWSWIRE) -- Turtle Beach Corporation...
May 07, 2026 16:00 ET | Source: Assembly Biosciences, Inc.

Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights

– Completed Phase 1b studies for ABI-5366 and ABI-1179, helicase-primase inhibitors for recurrent genital herpes – – Completed chronic toxicology studies for ABI-6250, an oral small-molecule entry...
May 07, 2026 16:00 ET | Source: INmune Bio, Inc.

INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update

BOCA RATON, Fla., May 07, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s...
May 07, 2026 15:45 ET | Source: E-Power Inc.

E-Power Subsidiary Awarded Key Patent for Advanced Silicon-Carbon Composite Materials, Strengthening Solid-State Battery Innovation

DOVER, USA, May 07, 2026 (GLOBE NEWSWIRE) -- E-Power Inc. (“E-Power”, the “Company”, “we” or “our”) (NASDAQ: EPOW), a leading provider of AI Data Center (AIDC) microgrid solutions and advanced...
May 07, 2026 15:00 ET | Source: Beacon Therapeutics (USA), Inc.

Beacon Therapeutics Announces Positive 12-Month Safety and Efficacy Update from Phase 2 DAWN Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2026 Annual Meeting

Data show promising and sustained improvements across key measures of visual function, including low luminance visual acuity and mean macular sensitivity as measured by microperimetry.Laru-zova was...
May 07, 2026 13:30 ET | Source: GlobalFoundries Inc.

GlobalFoundries Outlines Long-Term Growth Roadmap and Announces First-Ever Dividend at 2026 Investor Day

MALTA, N.Y., May 07, 2026 (GLOBE NEWSWIRE) -- Today at its 2026 Investor Day, GlobalFoundries (NASDAQ: GFS) highlighted clear opportunities for durable growth in AI-centric markets, expanding...
May 07, 2026 13:30 ET | Source: USA News Group

Greenland Mines (Nasdaq: GRML) Reports 45–55% PdEq Grade Uplift in Metal-Price Sensitivity at Skaergaard — While Western Critical Minerals Push Hits Inflection Point

Companies Mentioned: NASDAQ: GRML | NASDAQ: USAR KEY TAKEAWAYS Greenland Mines Ltd. (Nasdaq: GRML) has reported the results of an independent metal-price sensitivity analysis on its Skaergaard...